The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group
about
Neuropathic pain: a practical guide for the clinicianA genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucoseEffectiveness of a structured educational intervention using psychological delivery methods in children and adolescents with poorly controlled type 1 diabetes: a cluster-randomized controlled trial of the CASCADE interventionEffects of treatments for symptoms of painful diabetic neuropathy: systematic reviewPathways in the diagnosis and management of diabetic polyneuropathyDiabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatmentTreatment of diabetic sensory polyneuropathy.Maximising engagement, motivation and long term change in a Structured Intensive Education Programme in Diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE).Diabetic neuropathy: mechanisms to managementGlucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Cross-sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper.Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral NeuropathyInvestigation and Analysis of Hemoglobin A1c Measurement Systems' Performance for 135 Laboratories in China.Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyDifferent roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.Prevalence and correlates of diabetic peripheral neuropathy in a Saudi Arabic population: a cross-sectional study.Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC studyLow peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study.Improved A1C and Lipid Profile in Patients Referred to Diabetes Education Programs in a Wide Health Care Network: A Retrospective Study.Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT studyRacial disparities in diabetes-related preventive care: results from the Missouri Behavioral Risk Factor Surveillance SystemDuloxetine in the management of diabetic peripheral neuropathic pain.Update on the management of diabetic polyneuropathies.Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney diseaseErythropoietin both protects from and reverses experimental diabetic neuropathy.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Insulin resistance in the nervous systemScreening for diabetic cardiac autonomic neuropathy using a new handheld device.The factors associated with contact burns from therapeutic modalities.Description of the sphingolipid content and subspecies in the diabetic corneaRelationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy.Peripheral insensate neuropathy-is height a risk factor?Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.Advanced Diabetic Neuropathy: A Point of no Return?Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study.Pressure pain precedes development of type 2 disease in Zucker rat model of diabetes.
P2860
Q24553796-D0B5918C-A15C-4114-B644-36A092E8CFC0Q24642266-2859BA5C-BFA8-4BD7-AF8B-89CAB8C7B5BEQ24658543-6897EA50-BB9B-4167-8B8D-33C871393DB1Q24676584-7176EA34-A8B0-4540-A753-9A806D2C59A3Q28082465-13AA39C4-E121-4F6F-8D2F-AEBF26BAAF60Q33165286-8A805256-18D3-4028-BEF7-FE6343C8E36EQ33393882-23605C54-AB24-4D9C-AA29-AD79894B7FD5Q33503432-E0A760DE-65C2-47FB-B32B-CA923273FEE5Q33554384-C8B9D68C-46CA-4AA7-BC85-DCEFB820770DQ33569693-5511038E-A542-4D31-8717-B38BC270B578Q33583006-28C4C407-692F-4E01-B4FF-C8CF8748F373Q33585730-21F3147C-E520-4CE3-ADF8-074C821F3DF4Q33621822-61D0B5B1-199E-40D3-B629-B034669A5326Q33646688-C3445EDE-5E17-4FD9-88E2-BECB0CEC2C89Q33804684-E29824C8-6B14-43C0-945C-BDF684021972Q34086993-FB665DC1-1142-46A9-8F96-EDD3B30A62F0Q34128919-EB4BA6B1-AA5C-46AD-A6EC-B58001C54F1FQ34218901-F708853C-84A0-405B-91AA-9932029FB0C6Q34257700-9B26B0BE-40F1-4715-B915-5EA2D89AF8A6Q34277175-D3841360-0AAA-473E-ABCB-54FC601FC4F9Q34351852-3B20A548-9974-4EFD-8AB9-44C46AF55C31Q34351867-F09B81B0-A087-48E5-80F2-A7A7D0371F2EQ34510900-E5D2DA28-4D29-45A6-A5FC-F344194F210FQ35003495-FB5F408D-5180-413D-8147-2B0B711FE92AQ35131275-B910F6DE-E770-47DF-8DD4-16415B7E7F46Q35147185-B9E83F89-C200-47FA-AA06-BF8C34226593Q35178801-59B33BAE-93B0-40FA-AA29-BDF1A3DE8C02Q35211971-D4C63646-5643-4253-A652-615DDD500257Q35554405-5477F2AB-BAF3-469F-B14E-EABEA45EDDBFQ35896615-2486330B-BD01-4446-BB06-19958A5D5897Q36084516-8B9A392B-9509-42AB-A407-D53A97ADC27BQ36229348-C13B1FA0-C7EA-4514-9225-B3717CA96BBFQ36416909-B6AA2986-67EF-41D5-AD2F-5A944B8C5822Q36608066-0AF9095F-DC7C-47CB-B2A1-C6537B89E1C7Q36643969-CA0C74C2-3B48-4FCB-AFD1-65F618C818E2Q36668362-80A396E5-CE94-4A7E-B2FE-34A5977F39FCQ36810364-9C51A126-61B5-4014-AEA8-8BB46DBAB7BDQ36814825-007D067F-97E7-4832-96B9-44C3E3A2EE4CQ36842074-8F62DC31-81B8-4846-B75B-A495199DB388Q36978910-B0713D9E-7A31-4F88-A7F2-2D2451608FC8
P2860
The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The effect of intensive diabet ...... lications Trial Research Group
@ast
The effect of intensive diabet ...... lications Trial Research Group
@en
The effect of intensive diabet ...... lications Trial Research Group
@nl
type
label
The effect of intensive diabet ...... lications Trial Research Group
@ast
The effect of intensive diabet ...... lications Trial Research Group
@en
The effect of intensive diabet ...... lications Trial Research Group
@nl
prefLabel
The effect of intensive diabet ...... lications Trial Research Group
@ast
The effect of intensive diabet ...... lications Trial Research Group
@en
The effect of intensive diabet ...... lications Trial Research Group
@nl
P3181
P1476
The effect of intensive diabet ...... lications Trial Research Group
@en
P3181
P407
P577
1995-04-15T00:00:00Z